Skip to main content

Month: September 2024

New York Mortgage Trust Declares Third Quarter 2024 Common Stock Dividend of $0.20 Per Share, and Preferred Stock Dividends

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.20 per share on shares of its common stock for the quarter ending September 30, 2024. The dividend will be payable on October 28, 2024 to common stockholders of record as of the close of business on September 30, 2024. In addition, the Board declared cash dividends on the Company’s 8.000% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series D Preferred Stock”), 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series E Preferred Stock”), 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series F Preferred Stock”) and 7.000% Series G Cumulative...

Continue reading

Alliance Entertainment Reports Fourth Quarter and Fiscal Year 2024 Results

Operational efficiencies and margin improvements drive profitability turnaround Higher-margin DTC sales increased to 36% of gross revenue in FY24 Strengthened balance sheet with 45% reduction in revolver debt and added new $120M credit facility PLANTATION, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a global distributor and wholesaler specializing in music, movies, video games, electronics, arcades, toys, and collectibles, reported its financial and operational results for the fourth quarter and fiscal year ended June 30, 2024. FY 2024 and Subsequent Operational HighlightsNet revenue totaled $1.1 billion in fiscal year 2024. Gross profit increased to $128.9 million in fiscal year 2024, up 24% from the prior year, with gross margin improved 270bps to 11.7% on profitable sales...

Continue reading

Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad – 19 Sep 2024

At the close of business on 19 September 2024, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 23 September 2024:Vote according to voting instructions for 15,705,542 shares or 4.7% of the share capital and votes. Proxy to vote for 50,982,106 shares or 15.1% of the share capital and votes. 1,474,002 shares or 0.4% of the share capital and votes held by Mr. Opstad and close relations. Total 68,161,650 shares or 20.2% of the share capital and votes, including shares held by Mr. Opstad and close relations.Contact personMarianne Bøe, Head of Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: +47 9180 0186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication...

Continue reading

NorthEast Community Bancorp, Inc. Announces Increase in Quarterly Cash Dividend and Special Cash Dividend

WHITE PLAINS, N.Y., Sept. 19, 2024 (GLOBE NEWSWIRE) — NorthEast Community Bancorp, Inc. (the “Company”) (NasdaqCM: NECB) announced today that its Board of Directors has declared a special cash dividend of $0.15 per share on its outstanding common stock. Additionally, its Board of Directors has approved an increase in the Company’s quarterly cash dividend from $0.10 per share to $0.15 per share. The increased quarterly dividend and the special cash dividend will be paid on or about November 6, 2024 to shareholders of record as of the close of business on October 4, 2024. “We are pleased to increase our quarterly dividend to shareholders and to pay a special dividend,” said Kenneth A. Martinek, Chairman and Chief Executive Officer of the Company. “The payment of dividends continues to represent one part of our long-term commitment...

Continue reading

Sunrun CEO Mary Powell Named a 2024 Forbes’ Sustainability Leader

Forbes honors Sunrun CEO for her vision and inspiration to reduce fossil fuel dependence while strengthening the grid with customer-focused, distributed clean energy solutions SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, announced today that CEO Mary Powell has been named to Forbes’ inaugural list of Sustainability Leaders. The list highlights 50 of the world’s most inspiring leaders who are catalyzing a sustainable future through innovation and impact. Powell’s recognition by Forbes comes on the heels of Sunrun becoming the first and only solar-plus-storage company in the U.S. to surpass 1 million customers. “I am honored to join a group of leaders dedicated to innovating and driving a more customer centric sustainable future,” Powell...

Continue reading

Village Super Market Announces Forthcoming Change in Chief Executive Officer and Chairman of the Board of Directors

SPRINGFIELD, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) — Village Super Market, Inc. (NSD-VLGEA) today announced that Robert Sumas has notified the Board of Directors of his decision to step down as Chief Executive Officer and interim Chairman of the Board of Directors effective December 13, 2024. Mr. Sumas will remain employed by the Company as a Senior Advisor to the executive team to ensure a smooth transition of duties. Mr. Sumas also plans to continue to serve the Company as a member of its Board of Directors. Robert Sumas was appointed Chief Executive Officer and Vice Chairman of the Board of Directors in 2017 and served as President from 2009 through 2018. He has served variously as Executive Vice President, Chief Operating Officer, Secretary and a Director of the Company since 1969. The Company also announced that the Board...

Continue reading

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical functionWegovy® (semaglutide 2.4 mg) is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise function in people with obesity-related heart failure with preserved ejection fraction (HFpEF).The positive opinion is based on results from the STEP HFpEF and STEP HFpEF-DM trials, which showed that Wegovy® is an effective therapy compared to placebo for people with obesity-related HFpEF.1,2Bagsværd, Denmark, 19 September 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an...

Continue reading

MineSense XRF Scanning Testwork Confirms Ore Sorting Applicability at CuMo

Idaho Copper CorporationMineSense XRF shovel-based sensorsIdaho Copper CorporationMineSense XRF shovel-based sensorsBoise, Idaho, Sept. 19, 2024 (GLOBE NEWSWIRE) — Idaho Copper Corp. (OTC Pink: COPR) is pleased to announce that it has received initial results from scanning and amenability testwork performed using MineSense XRF scanning technology from representative samples of the three main geological zones at the CuMo Idaho copper-molybdenum-silver deposit. These samples were tested by MineSense at its Vancouver, BC, Canada facility, and involved a series of simulations:First, run of mine ore samples from each zone were repeatedly sent (ten times) through the MineSense XRF sensor ATM system, which replicates a mining shovel bucket Next, the ore was crushed to

Continue reading

UniFirst Corporation Announces Leadership Changes: Kelly Rooney Named Chief Operating Officer and Michael Croatti to Transition from Executive Role

WILMINGTON, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF), a North American leader in the supply and servicing of uniform and workwear programs, facility service products, and first aid and safety supplies, is pleased to announce the appointment of Kelly Rooney as Chief Operating Officer (COO), effective September 30, 2024. Rooney has extensive knowledge and experience in large-scale B2B route-based operations. Over her twenty-five plus year career, she has held operational and leadership roles of increasing responsibility. Her most recent position was as the Chief Human Resources Officer at Waste Management, a $20 billion public company. Rooney is returning to her roots and will oversee UniFirst’s day-to-day operations, focusing on driving growth, enhancing customer service excellence, and executing...

Continue reading

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments

Gimoti remains the sole proprietary FDA approved treatment for symptoms of diabetic gastroparesis SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti® (metoclopramide) nasal spray, reaffirms its commitment to improving the lives of patients suffering from diabetic gastroparesis in light of the recent decision by the U.S. Food and Drug Administration (FDA) to not approve Vanda Pharmaceuticals new drug application (NDA) for Tradipitant, an oral drug candidate for the treatment of symptoms in gastroparesis. Patients suffering from all forms of gastroparesis need additional agents to help treat this difficult disease, and we believe patients will be disappointed given...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.